These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1409747)
1. Neurodegeneration and gene dysregulation: studies utilizing the mouse trisomy 16 model of Down syndrome. Holtzman DM; Li Y; Gage FH; Epstein CJ; Mobley WC Prog Clin Biol Res; 1992; 379():227-44. PubMed ID: 1409747 [No Abstract] [Full Text] [Related]
2. Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Salehi A; Delcroix JD; Belichenko PV; Zhan K; Wu C; Valletta JS; Takimoto-Kimura R; Kleschevnikov AM; Sambamurti K; Chung PP; Xia W; Villar A; Campbell WA; Kulnane LS; Nixon RA; Lamb BT; Epstein CJ; Stokin GB; Goldstein LS; Mobley WC Neuron; 2006 Jul; 51(1):29-42. PubMed ID: 16815330 [TBL] [Abstract][Full Text] [Related]
3. Using mouse models to explore genotype-phenotype relationship in Down syndrome. Salehi A; Faizi M; Belichenko PV; Mobley WC Ment Retard Dev Disabil Res Rev; 2007; 13(3):207-14. PubMed ID: 17910089 [TBL] [Abstract][Full Text] [Related]
4. Mouse trisomy 16 as an animal model of human trisomy 21: a new approach for studying the pathogenesis of Down syndrome. Cox DR Mead Johnson Symp Perinat Dev Med; 1983; (22):23-7. PubMed ID: 6242492 [No Abstract] [Full Text] [Related]
7. Transcriptional profiling of a mouse model for Lafora disease reveals dysregulation of genes involved in the expression and modification of proteins. Ganesh S; Tsurutani N; Amano K; Mittal S; Uchikawa C; Delgado-Escueta AV; Yamakawa K Neurosci Lett; 2005 Oct; 387(2):62-7. PubMed ID: 16084644 [TBL] [Abstract][Full Text] [Related]
8. Protein dysregulation in mouse hippocampus polytransgenic for chromosome 21 structures in the Down Syndrome Critical Region. Shin JH; Gulesserian T; Verger E; Delabar JM; Lubec G J Proteome Res; 2006 Jan; 5(1):44-53. PubMed ID: 16396494 [TBL] [Abstract][Full Text] [Related]
9. Segmental trisomy as a mouse model for Down syndrome. Davisson MT; Schmidt C; Reeves RH; Irving NG; Akeson EC; Harris BS; Bronson RT Prog Clin Biol Res; 1993; 384():117-33. PubMed ID: 8115398 [TBL] [Abstract][Full Text] [Related]
10. Overexpression of amyloid precursor protein is associated with degeneration, decreased viability, and increased damage caused by neurotoxins (prostaglandins A1 and E2, hydrogen peroxide, and nitric oxide) in differentiated neuroblastoma cells. Hanson AJ; Prasad JE; Nahreini P; Andreatta C; Kumar B; Yan XD; Prasad KN J Neurosci Res; 2003 Oct; 74(1):148-59. PubMed ID: 13130517 [TBL] [Abstract][Full Text] [Related]
11. Endosomal abnormalities related to amyloid precursor protein in cholesterol treated cerebral cortex neuronal cells derived from trisomy 16 mice, an animal model of Down syndrome. Arriagada C; Astorga C; Atwater I; Rojas E; Mears D; Caviedes R; Caviedes P Neurosci Lett; 2007 Aug; 423(2):172-7. PubMed ID: 17706358 [TBL] [Abstract][Full Text] [Related]
12. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197 [TBL] [Abstract][Full Text] [Related]
13. Down syndrome and the trisomy 16 mouse: impact of gene imbalance on brain development and aging. Coyle JT; Oster-Granite ML; Reeves R; Hohmann C; Corsi P; Gearhart J Res Publ Assoc Res Nerv Ment Dis; 1991; 69():85-99. PubMed ID: 1825889 [No Abstract] [Full Text] [Related]
14. Metallothionein-I and -III expression in animal models of Alzheimer disease. Carrasco J; Adlard P; Cotman C; Quintana A; Penkowa M; Xu F; Van Nostrand WE; Hidalgo J Neuroscience; 2006 Dec; 143(4):911-22. PubMed ID: 17027170 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of amyloid precursor protein normalizes cholinergic function in a cell line derived from the cerebral cortex of a trisomy 16 mouse: An animal model of down syndrome. Opazo P; Saud K; de Saint Pierre M; Cárdenas AM; Allen DD; Segura-Aguilar J; Caviedes R; Caviedes P J Neurosci Res; 2006 Nov; 84(6):1303-10. PubMed ID: 16941497 [TBL] [Abstract][Full Text] [Related]
17. Molecular mapping of Alzheimer-type dementia in Down's syndrome. Prasher VP; Farrer MJ; Kessling AM; Fisher EM; West RJ; Barber PC; Butler AC Ann Neurol; 1998 Mar; 43(3):380-3. PubMed ID: 9506555 [TBL] [Abstract][Full Text] [Related]
18. [The development of the enteric nervous system in terisomy 16 mice with the occurrence of congenital megacolon]. Li J; Busch LC; Kunel W Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):466-9. PubMed ID: 11715446 [TBL] [Abstract][Full Text] [Related]
19. Progressive neuronal loss and behavioral impairments of transgenic C57BL/6 inbred mice expressing the carboxy terminus of amyloid precursor protein. Lee KW; Im JY; Song JS; Lee SH; Lee HJ; Ha HY; Koh JY; Gwag BJ; Yang SD; Paik SG; Han PL Neurobiol Dis; 2006 Apr; 22(1):10-24. PubMed ID: 16289866 [TBL] [Abstract][Full Text] [Related]
20. Chromosome 21 and down syndrome: from genomics to pathophysiology. Antonarakis SE; Lyle R; Dermitzakis ET; Reymond A; Deutsch S Nat Rev Genet; 2004 Oct; 5(10):725-38. PubMed ID: 15510164 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]